Levagen from Gencor earns ANVISA Novel Food Certification

Photo © iStockphoto.com/volk65

Agencia Nacional de Vigilancia Sanitaria (ANVISA), Brazil’s national health surveillance agency, certified Gencor’s (Irvine, CA) Levagen as a novel food. Within Brazil, this certification allows Gencor to market and sell Levagen as “ANVISA certified.”

“The ANVISA Novel Food certification opens the Brazilian market for Levagen and strengthens Gencor’s position as an innovator of ingredients that consumers can trust,” said R.V. Venkatesh, Gencor’s managing director, in a press release. “We are very happy to have achieved the certification and will continue to provide ingredients that are well-studied and convey benefits that consumers value.”

Levagen is a clinically studied form of palmitolethanolamide (PEA), which is a fatty acid amide that increases levels of anandamide, an endocannabinoid that regulates pain and sleep receptors.